Clinical Trial Update: Alternate Day Micafungin: A PK Study in Pediatric Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating alternate-day micafungin in pediatric patients with fungal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Fungal Infection | Phase 1 | Status: COMPLETED